Edition:
India

Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.40USD
23 Feb 2018
Change (% chg)

$0.02 (+1.45%)
Prev Close
$1.38
Open
$1.40
Day's High
$1.41
Day's Low
$1.37
Volume
46,132
Avg. Vol
139,956
52-wk High
$2.62
52-wk Low
$1.08

Latest Key Developments (Source: Significant Developments)

Athersys reports Q3 loss per share $0.06
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Athersys Inc :Athersys reports third quarter 2017 results.Q3 loss per share $0.06.Q3 revenue $400,000 versus $300,000.Q3 revenue view $598,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S.  Full Article

Athersys and Nikon Cell Innovation to collaborate on MultiStem manufacturing in Japan
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Athersys Inc ::Athersys and Nikon Cell Innovation to collaborate on multistem commercial manufacturing in Japan.Athersys - entered manufacturing services agreement with Nikon Cell for commercial production of its stem cell therapy in Japan for ischemic stroke.Athersys - technology transfer of stem cell production methods in preparation for potential commercialization in Japan after treasure clinical study.  Full Article

Athersys, FDA agree on design for ischemic stroke late-stage study
Wednesday, 28 Sep 2016 

Athersys Inc :Athersys receives FDA agreement under special protocol assessment for phase 3 study of multistem® treatment for ischemic stroke.  Full Article

Athersys qtrly loss per share $0.08
Wednesday, 10 Aug 2016 

Athersys Inc : Athersys reports second quarter 2016 results . Q2 revenue $600,000 versus $200,000 .Qtrly loss per share $0.08.  Full Article

BRIEF-Athersys Inc Files Prospectus Relates Potential Sale Of Up To 24.7 mln Shares Of Co's Common Stock By Aspire Capital

* ATHERSYS INC FILES PROSPECTUS RELATES POTENTIAL SALE OF UP TO 24.7 MILLION SHARES OF CO'S COMMON STOCK BY ASPIRE CAPITAL - SEC FILING‍​ Source text - (http://bit.ly/2nyf89E) Further company coverage: